Economy

Merck Boosts Profit Forecast as Key Medicines Top Estimates

Merck & Co. raised its full-year profit forecast after third-quarter results topped Wall Street’s expectations, fueled by stronger-than-anticipated sales of cancer blockbuster Keytruda and other newer medicines.